Annals of Emergency Medicine
Volume 56, Issue 1 , Pages 7-17 , July 2010

Treating Headache Recurrence After Emergency Department Discharge: A Randomized Controlled Trial of Naproxen Versus Sumatriptan

  • Benjamin W. Friedman, MD, MS

      Affiliations

    • Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY
    • Corresponding Author InformationAddress for correspondence: Benjamin W. Friedman, MD, MS, Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467; 718-920-6626, fax 718-798-0730
    • ,
  • Clemencia Solorzano, RPh

      Affiliations

    • Pharmacy Department, Montefiore Medical Center, Bronx, NY
    • ,
  • David Esses, MD

      Affiliations

    • Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Shujun Xia, MD, PhD

      Affiliations

    • Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Michael Hochberg, MD

      Affiliations

    • Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Niels Dua, MD, MS

      Affiliations

    • Division of Emergency Medicine, Columbia University Medical Center, New York, NY
    • ,
  • Alan Heins, MD, MPH

      Affiliations

    • Department of Emergency Medicine, University of South Alabama College of Medicine, Mobile, AL
    • ,
  • Paul Sasso, MD

      Affiliations

    • Division of Emergency Medicine, Columbia University Medical Center, New York, NY
    • ,
  • Polly E. Bijur, PhD

      Affiliations

    • Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY
    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Richard B. Lipton, MD

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
    • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • E. John Gallagher, MD

      Affiliations

    • Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY
    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY

Received 20 December 2009 ,Revised 26 January 2010 ,Accepted 3 February 2010.

References 

  1. Bigal M, Bordini CA, Speciali JG. Headache in an emergency room in Brazil. Sao Paulo Med J. 2000;118:58–62
  2. Friedman B, Hochberg m, Esses D, et al. Pain and functional outcomes of patients with primary headache disorder discharged from the emergency department [abstract]. Acad Emerg Med. 2006;13(5 suppl 1):S18
  3. McCaig LF, Nawar EW. National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. Adv Data. 2006;(372):1–29
  4. Friedman BW, Grosberg BM. Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am. 2009;27:71–87, viii
  5. Schwartz BS, Stewart WF, Simon D, et al. Epidemiology of tension-type headache. JAMA. 1998;279:381–383
  6. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–349
  7. Vinson DR. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med. 2002;39:215–222
  8. Akpunonu BE, Mutgi AB, Federman DJ, et al. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Ann Emerg Med. 1995;25:464–469
  9. Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med. 2002;23:141–148
  10. Cete Y, Dora B, Ertan C, et al. A randomized prospective placebo-controlled study of intravenous magnesium sulphate versus metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia. 2005;25:199–204
  11. Corbo J, Esses D, Bijur PE, et al. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med. 2001;38:621–627
  12. Ducharme J, Beveridge RC, Lee JS, et al. Emergency management of migraine: is the headache really over?. Acad Emerg Med. 1998;5:899–905
  13. Friedman BW, Corbo J, Lipton RB, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005;64:463–468
  14. Carleton SC, Shesser RF, Pietrzak MP, et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med. 1998;32:129–138
  15. Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med. 1995;2:597–602
  16. Miner JR, Fish S, Smith SW, et al. Droperidol versus prochlorperazine for benign headaches in the emergency department. Acad Emerg Med. 2001;8:873–879
  17. Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20:765–786
  18. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004;24(suppl 1):1–151
  19. Friedman BW, Hochberg ML, Esses D, et al. Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann Emerg Med. 2007;49:409–419419.e1-9
  20. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–762
  21. Andersson PG, Hinge HH, Johansen O, et al. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Cephalalgia. 1989;9:29–32
  22. Nestvold K, Kloster R, Partinen M, et al. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia. 1985;5:115–119
  23. Lipton RB, Steart WF, Cady R, et al. 2000 Wolfe Award (Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study). Headache. 2000;40:783–791
  24. Miner J, Bursell B, Smith S. Sumatriptan for the treatment of benign headaches in the emergency department [abstract]. J Acad Emerg Med. 2004;11:541
  25. Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003;10:390–392
  26. Friedman BW, Hochberg M, Esses D, et al. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines. Headache. 2006;46:934–941
  27. Kelly AM. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?. Acad Emerg Med. 1998;5:1086–1090
  28. Pascual J, Mateos V, Roag C, et al. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache. 2007;47:1152–1168
  29. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med. 1991;325:316–321
  30. Cady RK, Ruino J, Crummett D, et al. Oral sumatriptan in the treatment of recurrent headache. Arch Fam Med. 1994;3:766–772
  31. Ferrari MD, James MH, Bates D, et al. Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia. 1994;14:330–338
  32. Larkin GL, Prescott JE. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med. 1992;21:919–924
  33. Friedman BW, Hochberg ML, Esses D, et al. Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes. Ann Emerg Med. 2008;52:696–704
  34. Visser WH, Jaspers NM, de Vriend RH, et al. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia. 1996;16:264–269
  35. Tfelt-Hansen P. What can be learned from the history of recurrence in migraine? a comment. J Headache Pain. 2009;10:311–315
  36. Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for preventing recurrent migraine headaches: a systematic review of the literature. BMJ. 2008;336:1359–1361
  37. Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? a meta-analysis and systematic review of the literature. Acad Emerg Med. 2008;15:1223–1233
  38. Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr. 2000;58:428–430
  39. Cull RE, Price WH, Dunbar A. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache. J Neurol Neurosurg Psychiatry. 1997;62:490–495
  40. Teall J, Tuchman M, Cutler M, et al. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence (A placebo-controlled, outpatient study. Rizatriptan 022 Study Group). Headache. 1998;38:281–287
  41. Rapoport AM, Visser WH, Cutler NR, et al. Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology. 1995;45:1505–1509
  42. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA. 2007;297:1443–1454
  43. Smith TR, Sunshine A, Stark SR, et al. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2005;45:983–991
  44. Ho TW, Rodgers A, Bigal ME. Impact of recent prior opioid use on rizatriptan efficacy (A post hoc pooled analysis). Headache. 2009;49:395–403
  45. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache. 2006;46(suppl 4):S202–S211
  46. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–1168

 Please see page 8 for the Editor's Capsule Summary of this article.

 Provide feedback on this article at the journal's Web site, www.annemergmed.com.

 Supervising editor: Donald M. Yealy, MD

 Author contributions: BWF, CS, DE, ND, AH, PEB, and EJG conceived the study and designed the trial. BWF, DE, ND, AH, and PS supervised the conduct of the trial and data collection. BWF, DE, ND, and AH undertook recruitment of participating centers and patients and managed the data, including quality control. PEB, RBL, and EJG provided statistical advice on study design. BWF analyzed the data. BWF drafted the article, and all authors contributed substantially to its revision. BWF takes responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. Dr. Friedman is supported through a career development award (K23NS051409) from the National Institute of Neurological Disorders and Stroke.

 Publication date: Available online March 19, 2010.

 Reprints not available from the authors.

PII: S0196-0644(10)00118-6

doi: 10.1016/j.annemergmed.2010.02.005

Annals of Emergency Medicine
Volume 56, Issue 1 , Pages 7-17 , July 2010

Article Tools

* Image Usage & Resolution